Fundraising FoxVivo Capital — 2021 Investments
12 investments dated 2021 · listed companies and verified rows first · show all
Sera Prognostics develops women's health diagnostics focused on pregnancy, including the PreTRM blood test that predicts an individual's risk of spontaneous preterm birth in singleton pregnancies and the LikeMine platform that compares pregnancy outcomes using U.S. pregnancy data.
BiotechDigital HealthFemTechHealthtechSalt Lake City, US
Douglas Fisher(Executive Officer)Jay Moyes(Executive Officer)inGregory C. Critchfield(Executive Officer, Director)inAndrew A. Sauter(Executive Officer)inZhenya Lindgardt(President and Chief Executive Officer)in
BoardMansoor Mirza(Director)
Board seatJoseph Siletto· per SEC Form D
Co-investorsaMoonExcelestar VenturesIntermountain HealthOUP (Osage University Partners)UpStart VenturesCatalyst Health Ventures+1 more
Silence Therapeutics is a biotechnology company that discovers and develops short interfering RNA (siRNA) molecules designed to reduce the production of disease-associated proteins through the natural mechanism of RNA interference, with its proprietary mRNAi GOLD platform targeting specific genes in the liver for rare and common diseases.
BiotechLondon
Craig Tooman(Executive Officer)inGiles Campion(Executive Officer)Mark Rothera(Executive Officer, Director)inBarbara Ruskin(Executive Officer)
BoardJames Ede-Golightly(Director)Alistair Gray(Director)
Co-investorsForesite CapitalMC Healthcare VenturesNextech Invest
Esco Lifesciences manufactures laboratory equipment, biopharma devices, and IVF medical equipment for clinical, research, and industrial laboratories across more than 100 countries.
Advanced ManufacturingBiotechHardwareHealthtechMedical DevicesSingapore, SG
Lim Lay Yew(Founder)inLow Yae Foong(Founder)
Co-investorsGICNovo Holdings
HealthtechIrvine, US
Kenny Chang(Executive Officer)W. Ronald Redmond(Director)Vijay Dhaka(Executive Officer)Philong Pham(Executive Officer, Director)Hongsheng Tong(Executive Officer, Director)
Board seatJoseph Siletto· per SEC Form D
Co-investorsBlackRockEndeavour VisionMVM Life Science PartnersRTW Investments L.P.Soleus CapitalvenBio Global Strategic
A medical device company developing orthopedic and biological solutions.
BiotechCleantechHardwareHealthtechMedical DevicesOhio, US
David Kirschman(Surgeon Inventor)in
Co-investorsAsahi Kasei Corporate Venture CapitalHorizon Technology Finance
Co-investorsBain Capital Life Sciences
HistoWiz offers histopathology services for cancer researchers, processing mailed tissue specimens and producing digital whole-slide images accessible through a cloud-based virtual microscope.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesSaaSNew York City, US
Ke Cheng(CEO)inLinh Hoang(Chief Executive Officer)inJerry Kuang(Chief Operations Officer)Julie Feldstein(Chief Pathologist)in
Co-investorsAsahi Kasei Corporate Venture CapitalNew York AngelsvenBio PartnersY CombinatorAvlok CapitalK5 Ventures+1 more
IOBiotech appears to be a biotech company focused on oncology, with a founder who has extensive experience in cancer drug development and clinical advancement from roles at Roche, Eli Lilly, and leading academic cancer centers.
BiotechMedical Devices
Dr. Dhingra
Co-investorsAvoro Capital AdvisorsEIR VenturesKurma PartnersPivotal Life SciencesRA CapitalSamsara BioCapital+3 more
Neurogastrx is a biopharmaceutical company developing therapies for patients with gastrointestinal disorders.
BiotechHealthtechWoburn, US
Cyril De Colle(Founder)inJAMES DETORE(Executive Officer)JAMES O'MARA(Executive Officer, Director)inPAUL ROGERS(Executive Officer)in
BoardDAVID ALLISON(Director)inKLAUS VEITINGER(Director)in
Co-investors5AM VenturesOrbiMedSamsara BioCapitalvenBio PartnersRTW Investments L.P.venBio Global Strategic+1 more
Rgenta develops orally available small molecule therapies that target RNA to address diseases previously considered undruggable, with programs in oncology (targeting proteins such as MYB in solid tumors and hematologic cancers) and central nervous system repeat expansion disorders like Huntington's disease.
AI & Machine LearningBiotechDeep TechHealthtechCambridge, US
Travis Wager(Co-founder, President and CSO)inHualin Simon Xi(Executive Officer, Director)Zhiping Weng(Co-founder)inSimon Xi(Co-founder and CEO)inJackie Walling(CMO)Debasish Roychowdhury(Director)
Co-investorsDelos CapitalAMR Action FundBoehringer Ingelheim Venture FundKorea Investment PartnersLilly Asia VenturesMatrix Capital Management+1 more
Ronovo Surgical develops the Carina surgical robotics platform, including a vision system and instruments, for use by surgeons and hospitals.
HealthtechMedical DevicesRoboticsShanghai, CN
John Ma(Founder)inYing Mao(Founder)in
Co-investorsGranite AsiaINCE CapitalJJDCLilly Asia Ventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Ablaze Pharmaceuticals
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.